Search research articles
Contact Us
Filters
Showing results (261-270 of 297) with videos related to
Page
of 30
Sort By:
Arthritis Care & Research
|
August 29, 2013
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry
Lorinda Chung, Robyn T Domsic, Bharathi Lingala, et al.
Arthritis and Rheumatism
|
November 30, 2006
Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens
Richard K Burt, Alberto Marmont, Yu Oyama, et al.
The Journal of Allergy and Clinical Immunology
|
May 27, 2026
Multi-cytokine based TWAS for seven inflammatory skin disorders identify candidate causal genes in keratinocytes
Haihan Zhang, Matthew T Patrick, Mrinal K Sarkar, et al.
Nature Reviews. Rheumatology
|
March 3, 2025
Publisher Correction: An international perspective on the future of systemic sclerosis research
David J Abraham, Carol M Black, Christopher P Denton, et al.
Journal of Scleroderma and Related Disorders
|
October 9, 2024
Changes in work and adequacy of financial resources during COVID-19 among people with systemic sclerosis: A Scleroderma Patient-centered Intervention Network study
Claire Adams, Elsa-Lynn Nassar, Marie-Eve Carrier, et al.
Nature Communications
|
January 3, 2024
Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis
Feiyang Ma, Pei-Suen Tsou, Mehrnaz Gharaee-Kermani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 23, 2024
Targeting CD13/Aminopeptidase N as a Novel Therapeutic Approach for Scleroderma Fibrosis
Sei Muraoka, William D Brodie, Megan N Mattichak, et al.
The Journal of Rheumatology
|
October 3, 2018
Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry
Vivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Journal of Psychosomatic Research
|
June 11, 2020
Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients
Brett D Thombs, Linda Kwakkenbos, Marie-Eve Carrier, et al.
The New England Journal of Medicine
|
June 23, 2006
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P Tashkin, Robert Elashoff, Philip J Clements, et al.
Page
of 30
Search research articles
Search
Showing results (261-270 of 297) with videos related to
Sort By:
Page
of 30
Arthritis Care & Research
|
August 29, 2013
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry
Lorinda Chung, Robyn T Domsic, Bharathi Lingala, et al.
Arthritis and Rheumatism
|
November 30, 2006
Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens
Richard K Burt, Alberto Marmont, Yu Oyama, et al.
The Journal of Allergy and Clinical Immunology
|
May 27, 2026
Multi-cytokine based TWAS for seven inflammatory skin disorders identify candidate causal genes in keratinocytes
Haihan Zhang, Matthew T Patrick, Mrinal K Sarkar, et al.
Nature Reviews. Rheumatology
|
March 3, 2025
Publisher Correction: An international perspective on the future of systemic sclerosis research
David J Abraham, Carol M Black, Christopher P Denton, et al.
Journal of Scleroderma and Related Disorders
|
October 9, 2024
Changes in work and adequacy of financial resources during COVID-19 among people with systemic sclerosis: A Scleroderma Patient-centered Intervention Network study
Claire Adams, Elsa-Lynn Nassar, Marie-Eve Carrier, et al.
Nature Communications
|
January 3, 2024
Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis
Feiyang Ma, Pei-Suen Tsou, Mehrnaz Gharaee-Kermani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 23, 2024
Targeting CD13/Aminopeptidase N as a Novel Therapeutic Approach for Scleroderma Fibrosis
Sei Muraoka, William D Brodie, Megan N Mattichak, et al.
The Journal of Rheumatology
|
October 3, 2018
Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry
Vivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Journal of Psychosomatic Research
|
June 11, 2020
Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients
Brett D Thombs, Linda Kwakkenbos, Marie-Eve Carrier, et al.
The New England Journal of Medicine
|
June 23, 2006
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P Tashkin, Robert Elashoff, Philip J Clements, et al.
Page
of 30